Risk of hypokalemia developing during the therapy of DKA.
Matz
R
R
D016883:Diabetic Ketoacidosis / Q000628:therapy*; D005440:Fluid Therapy / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D007008:Hypokalemia / Q000209:etiology* / Q000503:physiopathology; D008275:Magnesium Deficiency / Q000209:etiology; D010758:Phosphorus / Q000097:blood; D011188:Potassium / Q000097:blood
D010758:Phosphorus; D011188:Potassium